|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0025663,
umls-concept:C0029925,
umls-concept:C0076726,
umls-concept:C0205179,
umls-concept:C0205314,
umls-concept:C0392762,
umls-concept:C0440744,
umls-concept:C0444498,
umls-concept:C0679622,
umls-concept:C1171362,
umls-concept:C1416678
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-6-26
|
|
pubmed:abstractText |
Kallikreins, a subgroup of the serine protease enzyme family, are considered important prognostic biomarkers in cancer. Here, we sought to determine the prognostic value of kallikrein 7 (hk7) in ovarian cancer using a novel method of compartmentalized in situ protein analysis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1271-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18325919-Automation,
pubmed-meshheading:18325919-Cohort Studies,
pubmed-meshheading:18325919-Disease-Free Survival,
pubmed-meshheading:18325919-Female,
pubmed-meshheading:18325919-Fluorescent Antibody Technique,
pubmed-meshheading:18325919-Fluorescent Dyes,
pubmed-meshheading:18325919-Follow-Up Studies,
pubmed-meshheading:18325919-Humans,
pubmed-meshheading:18325919-Image Processing, Computer-Assisted,
pubmed-meshheading:18325919-Immunohistochemistry,
pubmed-meshheading:18325919-Indoles,
pubmed-meshheading:18325919-Kallikreins,
pubmed-meshheading:18325919-Neoplasm Staging,
pubmed-meshheading:18325919-Ovarian Neoplasms,
pubmed-meshheading:18325919-Time Factors,
pubmed-meshheading:18325919-Tissue Array Analysis,
pubmed-meshheading:18325919-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression.
|
|
pubmed:affiliation |
Department of Medical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA. diamando.psyrri@yale.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
